LXE408 fumarate

TargetMol
Product Code: TAR-T39214L
Supplier: TargetMol
CodeSizePrice
TAR-T39214L-1mg1mg£337.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39214L-2mg2mg£470.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39214L-5mg5mg£573.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39214L-1mL1 mL * 10 mM (in DMSO)£812.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39214L-10mg10mg£870.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39214L-25mg25mg£1,251.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39214L-50mg50mg£1,669.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T39214L-100mg100mg£2,223.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
LXE408 fumarate is an orally active, non-competitive and kinetoplastid-selective?proteasome?inhibitor. LXE408 fumarate has an?IC50?of 0.04 μM for?L. donovani?proteasome and an?EC50?of 0.04 μM for?L. donovani. LXE408 fumarate has a low propensity to cross the blood brain barrier. LXE408 fumarate has the potential for visceral leishmaniasis (VL) research.
CAS:
0
Formula:
C27H22FN7O6
Molecular Weight:
559.51
Pathway:
Ubiquitination; Proteases/Proteasome
Purity:
0.98
SMILES:
0
Target:
Proteasome

References

Advait Nagle, et al. Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases. J Med Chem. 2020 Jul 15.